Am J Perinatol 2016; 33(14): 1377-1381
DOI: 10.1055/s-0036-1583191
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Analysis of the Physiological Variation in Neutrophil CD64 Expression during the Early Neonatal Period

Fuyu Miyake
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Masahiro Ishii
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Takayuki Hoshina
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Shun Ichikawa
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Shunsuke Araki
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Tadamune Kinjo
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Eiji Shibata
2   Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Toru Hachisuga
2   Department of Obstetrics and Gynecology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Koichi Kusuhara
1   Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
› Author Affiliations
Further Information

Publication History

25 November 2015

04 March 2016

Publication Date:
04 May 2016 (online)

Abstract

Background Several biomarkers for the diagnosis of sepsis are elevated during the early neonatal period due to physiological variations. The aim of this study was to investigate the physiological variation in neutrophil CD64 (nCD64) expression during the early neonatal period and the change in nCD64 expression in neonates with noninfectious diseases.

Methods Of 71 neonates enrolled in this prospective study, 5 and 51 were diagnosed as having bacteremia and noninfectious diseases, respectively. Fifteen healthy neonates were enrolled as normal controls. Peripheral white blood cell counts, serum C-reactive protein and procalcitonin levels, and nCD64 expression were examined at birth and on the first and fifth day of life in neonates with noninfectious diseases and healthy neonates. In neonates with bacteremia, these markers were measured at onset.

Results nCD64 expression was significantly higher in neonates with bacteremia (median, 1,992) than in those with noninfectious diseases (1,823, p < 0.001) and healthy neonates (1,848, p = 0.002). Unlike other biomarkers, no differences in nCD64 expression were observed on the same days between neonates with noninfectious diseases and healthy neonates.

Conclusion nCD64 expression may be a useful marker for the diagnosis of bacterial infection in the early neonatal period, because it does not show any physiological variations.

Supplementary Material

 
  • References

  • 1 Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed 2004; 89 (3) F229-F235
  • 2 van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4 (10) 620-630
  • 3 Hofer N, Müller W, Resch B. Non-infectious conditions and gestational age influence C-reactive protein values in newborns during the first 3 days of life. Clin Chem Lab Med 2011; 49 (2) 297-302
  • 4 Chiesa C, Pellegrini G, Panero A , et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 2003; 49 (1) 60-68
  • 5 Forest JC, Larivière F, Dolcé P, Masson M, Nadeau L. C-reactive protein as biochemical indicator of bacterial infection in neonates. Clin Biochem 1986; 19 (3) 192-194
  • 6 Gendrel D, Bohuon C. Procalcitonin, a marker of bacterial infection. Infection 1997; 25 (3) 133-134
  • 7 Hoffmann JJ. Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med 2009; 47 (8) 903-916
  • 8 Hoffmeyer F, Witte K, Schmidt RE. The high-affinity Fc gamma RI on PMN: regulation of expression and signal transduction. Immunology 1997; 92 (4) 544-552
  • 9 Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 2008; 121 (1) 129-134
  • 10 Van Lente F, Pippenger CE. The pediatric acute care laboratory. Pediatr Clin North Am 1987; 34 (1) 231-246
  • 11 Ishibashi M, Takemura Y, Ishida H, Watanabe K, Kawai T. C-reactive protein kinetics in newborns: application of a high-sensitivity analytic method in its determination. Clin Chem 2002; 48 (7) 1103-1106
  • 12 Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 2006; 91 (4) F283-F286
  • 13 Vouloumanou EK, Plessa E, Karageorgopoulos DE, Mantadakis E, Falagas ME. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med 2011; 37 (5) 747-762
  • 14 Layseca-Espinosa E, Pérez-González LF, Torres-Montes A , et al. Expression of CD64 as a potential marker of neonatal sepsis. Pediatr Allergy Immunol 2002; 13 (5) 319-327
  • 15 Fjaertoft G, Håkansson L, Foucard T, Ewald U, Venge P. CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants. Acta Paediatr 2005; 94 (3) 295-302
  • 16 Nupponen I, Pesonen E, Andersson S , et al. Neutrophil activation in preterm infants who have respiratory distress syndrome. Pediatrics 2002; 110 (1, Pt 1): 36-41
  • 17 Dilli D, Oğuz ŞS, Dilmen U, Köker MY, Kızılgün M. Predictive values of neutrophil CD64 expression compared with interleukin-6 and C-reactive protein in early diagnosis of neonatal sepsis. J Clin Lab Anal 2010; 24 (6) 363-370